Home › Funds › EDMOND DE ROTHSCHILD HOLDING S.A. › XRAY

EDMOND DE ROTHSCHILD HOLDING S.A. position in XRAY

DENTSPLY SIRONA INC · Health Care

EDMOND DE ROTHSCHILD HOLDING S.A. reported holding 4,503,300 shares of XRAY (DENTSPLY SIRONA INC) in its Q2 2026 13F filing — a position valued at US$47.8M, representing 0.64% of its reported portfolio and ranking #44 among its reported holdings. EDMOND DE ROTHSCHILD HOLDING S.A. has disclosed XRAY holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)4.50M sh
Reported value held$47.78M
Portfolio Weight0.64%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EDMOND DE ROTHSCHILD HOLDING S.A.'s XRAY position evolved

EDMOND DE ROTHSCHILD HOLDING S.A. first disclosed a stake in XRAY in Q4 2023 at 205,800 shares (US$7.3M). The position peaked in Q2 2025 at 3,087,300 shares, worth US$49.0M. Across 11 filings, EDMOND DE ROTHSCHILD HOLDING S.A. increased the stake 10 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,503,300 shares valued at US$47.8M — an increase of 325,000 shares quarter over quarter.. Notable position changes include a 398% increase in Q1 2024 (shares fell 25% over the following quarter), a 48% increase in Q2 2024 (shares rose 9% over the following quarter), a 41% increase in Q4 2024 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 205.80K $7.32M New
Q1 2024 1.03M $34.03M Add
Q2 2024 1.52M $37.91M Add
Q3 2024 1.63M $44.16M Add
Q4 2024 2.30M $43.73M Add
Q1 2025 2.91M $43.53M Add
Q2 2025 3.09M $49.03M Add
Q3 2025 3.44M $43.62M Add
Q4 2025 3.62M $41.35M Add
Q1 2026 4.18M $48.47M Add
Q2 2026 4.50M $47.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XRAY and 13F data

XRAY (DENTSPLY SIRONA INC) is a Health Care company. 13 other funds we track also report a position in XRAY — the largest reported positions include ARIEL INVESTMENTS, LLC (US$85.2M), Southpoint Capital Advisors LP (US$74.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XRAY

All XRAY fund holders →

FAQ

How long has EDMOND DE ROTHSCHILD HOLDING S.A. held XRAY?

EDMOND DE ROTHSCHILD HOLDING S.A. has disclosed XRAY holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is EDMOND DE ROTHSCHILD HOLDING S.A.'s current position in XRAY?

As of Q2 2026, EDMOND DE ROTHSCHILD HOLDING S.A. holds 4.50M shares of XRAY (DENTSPLY SIRONA INC), valued at $47.78M, representing 0.64% of its reported portfolio and ranking #44.

Has EDMOND DE ROTHSCHILD HOLDING S.A. been buying or selling XRAY?

In the latest 13F filing (Q2 2026), EDMOND DE ROTHSCHILD HOLDING S.A. increased its position in XRAY. The position peaked in Q2 2025 at 3.09M shares.

Which other funds hold XRAY?

Other major institutional holders of XRAY include ARIEL INVESTMENTS, LLC, Southpoint Capital Advisors LP, among 13 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.